GLNE 003: Preliminary Validation of Biomarkers Predictive of Barrett’s Esophagus Progression to Dysplasia and Adenocarcinoma
- Abbreviated Name
- GLNE 003: Preliminary Validation of Biomarkers Predictive of Barrett’s Esophagus Progression to Dysp
- Lead Investigator
- — University of Michigan
- Coordinating Investigator
- No coordinating investigator
- Involved Investigators
Abstact
Aims
Establish the feasibility of measuring the biomarkers in a multi-center clinical trial. 1.2 Estimate the variance of the biomarkers in cohorts defined by sex, race, age and histologic diagnosis (Barrett's intestinal metaplasia, Barrett's intestinal dysplasia [low-grade or high-grade], Adenocarcinoma, and non-Barrett’s controls). 1.3 Determine if the distributions of the biomarkers differ significantly among patients with different histologic diagnoses.
Analytic Method
Biomarkers
- No biomarkers available at this time for this protocol
Data Collections
- No data available at this time for this protocol
- Protocol ID
- 107
- Protocol Type
- Collaboration
- Field of Research
- Glycomics
- Collaborative Group
- G.I. and Other Associated Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of esophagus